News Synmosa Biopharma Corporation

Equities

4114

TW0004114004

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
38.75 ^TWD	-0.13%		+1.71%	+0.26%

Mar. 29	Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 16	Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee	Jan. 16	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 12	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Synmosa Biopharma Corporation Announces Cash Dividend, Payable on September 15, 2023	23-07-24	CI
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Additional Independent Director	23-07-13	CI
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Member of the Audit Committee	23-07-13	CI
Synmosa Biopharma Corporation announced that it expects to receive TWD 950 million in funding	23-06-20	CI
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Synmosa Biopharma Corporation Approves Dividend for the Year Ended December 31, 2022	23-03-13	CI
Synmosa Biopharma Corporation Announces Changes of Corporate Governance Officer	23-01-18	CI
Synmosa Biopharma Corporation Provides Earnings Guidance for the Year 2022	22-11-27	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
Synmosa Biopharma : The Company is invited to attend institutional investor conference held by IBF Securities	22-08-17	PU
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Synmosa Biopharma : To announces SYNMOSA board of directors has lifted the restriction on the prohibition of competition for managerial officer	22-08-11	PU
Synmosa Biopharma : The Company's 2022 Second quarter consolidated financial statements have been reported to the Board	22-08-11	PU
Synmosa Biopharma : Announcement of the Company's adjustment of the number for the transfer treasury shares to employees through the resolution of the board of directors on 7/29	22-08-02	PU
Synmosa Biopharma : Announcement of the Company's board of directors resolution on transfer treasury shares to employees and the record date of share subscription	22-07-29	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Synmosa Biopharma Corporation

Equities

4114

TW0004114004

Summary

Filters